Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
18
Added to
26
Trimmed
18
Exited
8
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $16.24B across 111 positions in their Q1 2020 SEC 13F filing (period ending 2020-03-31). The top 10 positions account for 86.3% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENEURSeattle Genetics, Inc. | $5.78B | 35.57% | +0.0% |
| 2 | INCYIncyte Corporation | $2.34B | 14.42% | +0.0% |
| 3 | ACADACADIA Pharmaceuticals Inc. | $1.77B | 10.90% | +2.6% |
| 4 | ONCBeiGene, Ltd. | $1.45B | 8.93% | - |
| 5 | ALXNAlexion Pharmaceuticals, Inc. | $786.63M | 4.84% | +6.1% |
| 6 | BMRNBioMarin Pharmaceutical Inc. | $641.29M | 3.95% | - |
| 7 | KODKodiak Sciences Inc. | $552.11M | 3.40% | +4.8% |
| 8 | ASNDUSDAscendis Pharma A/S | $381.78M | 2.35% | - |
| 9 | 1K0IGM Biosciences, Inc. | $176.54M | 1.09% | - |
| 10 | Amarin Corporation plc | $137.99M | 0.85% | - |
| Stock | Value | Shares |
|---|---|---|
| ADAPYAdaptimmune Therapeutics plc | $10.04M | 3,690,307 |
| ALECAlector, Inc. | $6.76M | 280,000 |
| BDSIUSDBioDelivery Sciences International, Inc. | $6.21M | 1,638,334 |
| Horizon Therapeutics Public Ltd Co | $5.92M | 200,000 |
| PRTOUSDArTara Therapeutics, Inc. | $4.59M | 199,671 |
| PASGPassage Bio, Inc. | $4.33M | 275,000 |
| IMMUImmunomedics, Inc. | $4.18M | 310,000 |
| NERVGBPMinerva Neurosciences, Inc. | $4.14M | 688,531 |
| Karuna Therapeutics, Inc. | $3.02M | 41,976 |
| XLRNAcceleron Pharma Inc. | $2.43M | 27,000 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.